Abstract:Due to an inability to ethically access developing human brain tissue as well as identify prospective cases, early-arising neurodevelopmental and cell-specific signatures of Schizophrenia (Scz) have remained unknown and thus undefined. To overcome these challenges, we utilized patient-derived induced pluripotent stem cells (iPSCs) to generate 3D cerebral organoids to model neuropathology of Scz during this critical period. We discovered that Scz organoids exhibited ventricular neuropathology resulting in altered progenitor survival and disrupted neurogenesis. This ultimately yielded fewer neurons within developing cortical fields of Scz organoids. Single-cell sequencing revealed that Scz progenitors were specifically depleted of neuronal programming factors leading to a remodeling of cell-lineages, altered differentiation trajectories, and distorted cortical cell-type diversity. While Scz organoids were similar in their macromolecular diversity to organoids generated from healthy controls (Ctrls), four GWAS factors (PTN, COMT, PLCL1, and PODXL) and peptide fragments belonging to the POU-domain transcription factor family (e.g., POU3F2/BRN2) were altered. This revealed that Scz organoids principally differed not in their proteomic diversity, but specifically in their total quantity of disease and neurodevelopmental factors at the molecular level. Single-cell sequencing subsequently identified cell-type specific alterations in neuronal programming factors as well as a developmental switch in neurotrophic growth factor expression, indicating that Scz neuropathology can be encoded on a cell-type-by-cell-type basis. Furthermore, single-cell sequencing also specifically replicated the depletion of BRN2 (POU3F2) and PTN in both Scz progenitors and neurons. Subsequently, in two mechanistic rescue experiments we identified that the transcription factor BRN2 and growth factor PTN operate as mechanistic substrates of neurogenesis and cellular survival, respectively, in Scz organoids. Collectively, our work suggests that multiple mechanisms of Scz exist in patient-derived organoids, and that these disparate mechanisms converge upon primordial brain developmental pathways such as neuronal differentiation, survival, and growth factor support, which may amalgamate to elevate intrinsic risk of Scz.

Altered neuronal migratory trajectories in human cerebral organoids derived from individuals with neuronal heterotopia

Neuronal Hyperactivity in Neurons Derived from Individuals with Grey Matter Heterotopia

Cerebral organoids model human brain development and microcephaly

The generation and properties of human cortical organoids as a disease model for malformations of cortical development

From naïve pluripotency to human neural organoids through a three-dimensional morphogenetic continuum

MDB-25. ESTABLISHING A NOVEL CEREBELLAR ORGANOID MODEL FOR INVESTIGATING HEREDITARY PREDISPOSITION TO CHILDHOOD BRAIN CANCER

Modeling primary microcephaly with human brain organoids reveals fundamental roles of CIT kinase activity

PTCH1 -mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis

Cell-type specific defects in PTEN -mutant cortical organoids converge on abnormal circuit activity

Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences

Maturation and circuit integration of transplanted human cortical organoids

Loss of impacts both neuronal and non-neuronal cells in human cerebral organoids

Sliced Human Cortical Organoids for Modeling Distinct Cortical Layer Formation.

Human brain organoids reveal accelerated development of cortical neuron classes as a shared feature of autism risk genes

Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases

GABA/Glutamate neuron differentiation imbalance and increased AKT/mTOR signalling in CNTNAP2 cerebral organoids

Molecular and network disruptions in neurodevelopment uncovered by single cell transcriptomics analysis of CHD8 heterozygous cerebral organoids

Neuronal Defects in a Human Cellular Model of 22q11.2 Deletion Syndrome.

Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations

Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes

Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids